A Louisiana middle school teacher, recently honored as 'Teacher of the Year,' has been arrested on additional charges related to alleged inappropriate conduct with a former student, deepening a scandal that has rocked the local school district.
Eikon Therapeutics, a biotech firm founded by Nobel laureate Eric Betzig, raised $381.2 million in its Nasdaq debut, pricing shares at $18. The offering signals renewed investor confidence in the biotech IPO market after a prolonged slowdown.
A sharp rise in measles cases across North America is putting the hard-won 'elimination' status of the United States and Mexico at risk, as health officials call for urgent action to boost vaccination and surveillance.
After a significant pullback in its share price, Netflix finds itself at a critical valuation crossroads. We analyze the numbers behind the recent weakness and what they mean for investors gauging the company's future.
As Repligen signals a steadying order book from key biopharma clients and strength in gene therapy, investors are weighing its lofty valuation against a mixed performance record and sector headwinds.
Tesla's stock, a bellwether for the electric vehicle revolution, faces intense scrutiny as valuation metrics signal a significant premium. While long-term returns remain impressive, recent volatility and fundamental analysis raise questions about whether the current price fully accounts for mounting competition and execution risks.
While both the Dow Jones Industrial Average and the S&P 500 are ubiquitous market barometers, their methodologies tell vastly different stories. We dissect the history, composition, and inherent biases of these two indices to determine which one truly captures the heartbeat of the U.S. economy.
Defense contractor Raytheon has secured multiple Pentagon agreements to dramatically increase output of key missile systems, a move that comes weeks after the Trump administration threatened to sever contracts over production delays.
Verizon Communications' stock has surged over 25% in the past year, prompting investors to question if its current price still reflects underlying value. A deep dive into cash flow projections and valuation metrics suggests significant upside may remain.
CSG Systems International (CSGS) shares are trading near analyst fair value estimates and a key cash offer price, prompting investors to assess whether the current valuation fully reflects the company's prospects and risks.
CNBC's Jim Cramer has taken a contrarian stance on Chipotle Mexican Grill, suggesting the market's negative reaction to its latest earnings report is misguided and that the stock's recent comeback has more room to run.
Oracle's ambitious plan to raise up to $50 billion for a massive AI infrastructure expansion has rattled investors, sending its stock down sharply. While the move underscores its commitment to competing with cloud leaders, concerns over execution risk and debt levels are taking center stage.
STERIS plc's shares have climbed over 20% in the past year, prompting a critical valuation debate. While a discounted cash flow model suggests the stock is fairly priced, its elevated P/E ratio compared to industry peers raises questions about its current premium. We examine the metrics and investor narratives shaping the outlook for this healthcare infrastructure leader.
Amidst a cautious market environment shaped by RBA rate hikes and global tech volatility, a closer look reveals resilient opportunities. We examine three ASX-listed penny stocks—from biotech to mining—that are navigating the headwinds with distinct strategies and potential.
At a major Wall Street Journal conference in Palm Beach, financial leaders from Blackstone, Citi, and Lazard grappled with the immediate market fallout and long-term implications of an AI startup's latest move, revealing a stark divide between panic and opportunity.
While the average retiree collects around $2,000 monthly, a select few are on track for benefits exceeding $5,000 next year. Achieving this maximum, however, requires a career path few would choose—and financial experts question its true value for most.
Venezuela's leading legal rights group confirms the release of 22 more individuals, including a journalist, as part of a disputed prisoner liberation initiative announced by the interim government last month.
CNBC's Jim Cramer offered a nuanced assessment of Marvell Technology, praising its execution but labeling it a 'derivative' company in the competitive semiconductor landscape, sparking debate among investors.
A faster-than-expected coronal mass ejection, triggered by a major solar flare, has heightened forecasts for a widespread aurora borealis display visible from multiple northern U.S. states Wednesday night into Thursday morning.
A viral Reddit post from a millennial earning over $250,000, expressing bewilderment at an inability to build savings, has ignited a fierce debate about the real cost of financial stability in today's economy, highlighting a generational squeeze felt even by top earners.
